Evidence map›Paper›PMID 28704522›Full record

ArticlePloS one2017

Assessment of gut microbiota populations in lean and obese Zucker rats.

Reza Hakkak, Soheila Korourian, Steven L Foley, Bruce D Erickson

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. AdultBiomolecules · 2026
    Article
  2. Article
  3. An ethically guided preclinical device for phenotyping HAnimal models and experimental medicine · 2024
    Article
  4. Spirulina (Nutrients · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Potential Roles of the Gut Microbiota in Pancreatic Carcinogenesis and Therapeutics.Frontiers in cellular and infection microbiology · 2022
    Review
  9. Article
  10. Short-Term Metformin Treatment EnrichesFrontiers in microbiology · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Reza HakkakDepartment of Dietetics and Nutrition, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.ORCID http://orcid.org/0000-0003-4829-8478
Soheila KorourianDepartment of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.
Steven L FoleyNational Center for Toxicological Research, US Food and Drug Administration, Jefferson, Arkansas, United States of America.
Bruce D EricksonNational Center for Toxicological Research, US Food and Drug Administration, Jefferson, Arkansas, United States of America.
National Center for Toxicological Research · USArkansas Children's Hospital · USUniversity of Arkansas for Medical Sciences · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity has been on the rise in the US and worldwide for the last several decades. Obesity has been associated with chronic disease development, such as certain types of cancer, type 2 diabetes, cardiovascular disease, and liver diseases. Previously, we reported that obesity promotes DMBA-induced mammary tumor development using the obese Zucker rat model. The intestinal microbiota is composed of a diverse population of obligate and facultative anaerobic microorganisms, and these organisms carry out a broad range of metabolic activities. Obesity has been linked to changes in the intestinal microbiota, but the composition of the bacterial populations in lean and obese Zucker rats has not been carefully studied. Therefore, the objective of this study was to determine the effects of obesity on the gut microbiota in this model. Lean and obese female Zucker rats (n = 16) were fed an AIN-93G-like diet for 8 weeks. Rats were weighed twice weekly, and fecal samples were collected at the beginning and end of the experiment. 16S rRNA gene sequencing was used to evaluate the composition of the fecal bacterial populations. At the outset of the study, the lean rats exhibited much lower ratios of the Firmicutes to Bacteroidetes phyla than the obese rats, but after 60 days, this ratio in the lean rats exceeded that of the obese. This shift was associated with reductions in the Bacteroidaceae, S24-7 and Paraprevotellaceae families in the lean rats. Obese rats also showed increased levels of the genus Akkermansia at day 60. PCoA plots of beta diversity showed clustering of the different test groups, indicating clear differences in intestinal microbiota populations associated with both the time point of the study and the lean or obese status in the Zucker rat model for obesity.

Indexed as

AnimalsBody WeightFecesFemaleGastrointestinal MicrobiomeObesityPhylogenyRatsRats, ZuckerThinness

Identifiers

PMID28704522
PMCPMC5509373
OpenAlexW2734505806

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.